Letter to the editor: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions
- PMID: 29984344
- PMCID: PMC6028461
- DOI: 10.4111/icu.2018.59.4.280
Letter to the editor: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions
Conflict of interest statement
CONFLICTS OF INTEREST: The authors have nothing to disclose.
Comment in
-
The authors reply: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.Investig Clin Urol. 2018 Jul;59(4):282. doi: 10.4111/icu.2018.59.4.282. Epub 2018 Jun 14. Investig Clin Urol. 2018. PMID: 29984345 Free PMC article. No abstract available.
Comment on
-
Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.Investig Clin Urol. 2018 Jan;59(1):61-65. doi: 10.4111/icu.2018.59.1.61. Epub 2017 Dec 21. Investig Clin Urol. 2018. PMID: 29333517 Free PMC article.
References
-
- Wu YN, Wu CC, Sheu MT, Chen KC, Ho HO, Chiang HS. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J Tissue Eng Regen Med. 2016;10:E294–E304. - PubMed
-
- Spartalis ED, Tomos P, Dimitroulis D, Kouraklis G. Platelet-rich plasma in surgical oncology. Surg Innov. 2014;21:441. - PubMed
-
- Spartalis E, Moris D, Dimitroulis D, Tomos P. Postresectional airway fistula occlusion via stem-cell transplantation: is it oncologically safe. Ann Thorac Surg. 2015;100:2413–2414. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
